Pharma IQ Logo IQPC Home Page

Webcasts

 
Prodrug Approaches to Improve Solubility Behavior -What, When and How?
• Review of common physicochemical approaches to address solubility issues
• How can we incorporate prodrug strategies as part of drug discovery
• Some recent studies

 
Reviewing the latest initiatives for drug safety surveillance from the FDA
• Describing the initiatives from the FDA and determining their impact on your pharmacovigilance strategy and organisation
• Comparing these with EMEA and worldwide directives
• Understanding the impact and implications of FDAAA on drug development and commercialisation
 
The Management of Compound Management: How to get buy in for CM
• Managing change in the collaborative role of CM in the drug discovery organisation – how can we be most flexible in our integrated role?
• Responding to new requirements and trends in target based screening
• The secret to success of managing a CM team
• Steps on how to demonstrate the value of CM to key partners

 

Upcoming Events

  • Operational Excellence in Pharmaceuticals and Medical Devices
    Deliver your business goals by driving innovation, growth and productivity
    October 14 - 16, 2008 * New Connaught Rooms, London, UK
  • Cold Chain Management for Pharmaceuticals 2008
    Ensure product integrity, patient security and timely delivery through enhanced cold chain management
    October 20 - 23, 2008 * Rendezvous Hotel, Singapore
  • Pharmakovigilanz 2008
    Neue EU Guidelines und Referentenentwürfe - Good Vigilance Practice - Workflows & Kovigilanz Reporting
    October 20 - 22, 2008 * Le Méridien, Frankfurt am Main, Deutschland
  • Pharma Sales Force 2008
    Marketing Excellence & Sales Force Effectiveness
    October 20 - 23, 2008 * Mélia Hotel, Berlin, Deutschland
  • Pharma Secure Chain 2008
    Lock Down Security against Counterfeit Medicines: Protect your Revenue and Reputation
    October 21 - 22, 2008 * Thistle Marble Arch, London, UK
View All Events